The Permanent Representatives Committee (Coreper 1) of the EU Council, in a provisional agenda published on 26 June 2026, is set to advance over 20 legislative and preparatory items during meetings on 24 and 30 June, covering environment, transport, research, employment, health, and fisheries. The agenda includes preparing the Environment Council (25 June) and Transport/Energy Council (26 June), as well as the EPSCO Council (29 June).
On 24 June, Coreper 1 will discuss a compromise text on the market stability reserve for buildings, road transport, and additional sectors (document 10592/26), ahead of the Environment Council. Transport items include preparing trilogues on passenger rights enforcement regulation (10749/26) and the Eurovignette Directive amendment (10644/26). In research, the committee will examine the Horizon Europe 2028-2034 Framework Programme (10457/1/26 REV 1) for a partial general approach. For employment and social policy, it will endorse the 2026 country-specific recommendations (10400/26) and approve employment/social policy aspects (10361/26).
The second day, 30 June, will analyse a compromise text on the posting workers declaration interface (10977/26) and receive debriefs on trilogues concerning passenger rights, France's accession to the Sea Turtles Convention, and the ECHA regulation. A key health item is the analysis of the Critical Medicines Act compromise text (10713/26).
The annex lists I items for adoption without debate, including appointments of members from Denmark, Luxembourg, and Belgium to various boards, legislative acts on CMO reform, vehicle circularity, waste export ban, and fishing opportunities for 2026-2028. Notably, the EU-UK Gibraltar agreement (6432/26) is set for approval via written procedure.
Stakeholder impact The agenda affects multiple stakeholders. EU producers in sectors like transport and fisheries face new compliance requirements from the Eurovignette amendment and fishing quotas. EU consumers may benefit from enhanced passenger rights enforcement. National authorities will implement the market stability reserve and critical medicines act, requiring administrative adjustments. EU taxpayers could see long-term savings from Horizon Europe's research investments, though short-term costs arise from regulatory changes. The Critical Medicines Act aims to reduce supply vulnerabilities, benefiting public health systems, but may increase costs for pharmaceutical companies due to new obligations.
Institutional follow-up Following Coreper 1's preparatory work, the Environment, Transport/Energy, and EPSCO Councils will take final decisions on the respective files. Trilogue outcomes on passenger rights and other dossiers will proceed to the European Parliament for approval. The EU-UK Gibraltar agreement, once adopted by the Council, will require ratification by member states.